These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8613491)

  • 1. Molecular structure of staphylococcus and streptococcus superantigens.
    Schlievert PM; Bohach GA; Ohlendorf DH; Stauffacher CV; Leung DY; Murray DL; Prasad GS; Earhart CA; Jablonski LM; Hoffmann ML; Chi YI
    J Clin Immunol; 1995 Nov; 15(6 Suppl):4S-10S. PubMed ID: 8613491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
    Bohach GA; Fast DJ; Nelson RD; Schlievert PM
    Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
    Smith RJ; Schlievert PM; Himelright IM; Baddour LM
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of streptococcal and staphylococcal superantigens in septic shock.
    Bannan J; Visvanathan K; Zabriskie JB
    Infect Dis Clin North Am; 1999 Jun; 13(2):387-96, ix. PubMed ID: 10340173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural evidence for the evolution of pyrogenic toxin superantigens.
    Mitchell DT; Levitt DG; Schlievert PM; Ohlendorf DH
    J Mol Evol; 2000 Dec; 51(6):520-31. PubMed ID: 11116326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolysins augment superantigen penetration of stratified mucosa.
    Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
    J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology.
    Betley MJ; Borst DW; Regassa LB
    Chem Immunol; 1992; 55():1-35. PubMed ID: 1418613
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
    Schlievert PM
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S107-10. PubMed ID: 11586276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.
    Schlievert PM; Jablonski LM; Roggiani M; Sadler I; Callantine S; Mitchell DT; Ohlendorf DH; Bohach GA
    Infect Immun; 2000 Jun; 68(6):3630-4. PubMed ID: 10816521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis.
    Hackett SP; Stevens DL
    J Infect Dis; 1993 Jul; 168(1):232-5. PubMed ID: 8515117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical aspects of streptococcal and staphylococcal toxinic diseases].
    Floret D
    Arch Pediatr; 2001 Sep; 8 Suppl 4():762s-768s. PubMed ID: 11582925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
    Leung DY; Meissner C; Fulton D; Schlievert PM
    J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of toxic shock syndrome toxin 1.
    Prasad GS; Earhart CA; Murray DL; Novick RP; Schlievert PM; Ohlendorf DH
    Biochemistry; 1993 Dec; 32(50):13761-6. PubMed ID: 8268150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigens: microbial agents that corrupt immunity.
    Llewelyn M; Cohen J
    Lancet Infect Dis; 2002 Mar; 2(3):156-62. PubMed ID: 11944185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of streptococcal pyrogenic exotoxin A and staphylococcal toxic shock syndrome toxin-1 in Bacillus subtilis.
    Kreiswirth BN; Handley JP; Schlievert PM; Novick RP
    Mol Gen Genet; 1987 Jun; 208(1-2):84-7. PubMed ID: 3112526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.
    Alouf JE; Müller-Alouf H
    Int J Med Microbiol; 2003 Feb; 292(7-8):429-40. PubMed ID: 12635926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
    Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
    Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of pyrogenic exotoxin "superantigens" of group A streptococci and Staphylococcus aureus.
    Lee PK; Schlievert PM
    Curr Top Microbiol Immunol; 1991; 174():1-19. PubMed ID: 1802616
    [No Abstract]   [Full Text] [Related]  

  • 19. Superantigens: structure-function relationships.
    Baker MD; Acharya KR
    Int J Med Microbiol; 2004 Apr; 293(7-8):529-37. PubMed ID: 15149028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defense against biologic warfare with superantigen toxins.
    Kaempfer R; Arad G; Levy R; Hillman D
    Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.